1 Treatment procedures and associated medical costs of methicillin-resistant infection in Japan: A retrospective analysis using a database of Japanese employment-based health insurance.

2 Label-Free Quantitative Proteomics Reveals the Multitargeted Antibacterial Mechanisms of Lactobionic Acid against Methicillin-Resistant (MRSA) using SWATH-MS Technology.

3 Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.

4 Pulsed 450 nm blue light suppresses MRSA and Propionibacterium acnes in planktonic cultures and bacterial biofilms.

5 methicillin-resistant staphylococcus aureus in cystic fibrosis patients: do we need to care? a cohort study

6 evaluation of methods in detecting vancomycin mic among mrsa isolates and the changes in accuracy related to different mic values

7 prevalence of methicillin-resistant staphylococcus aureus (mrsa) and antibiotic resistance patterns of the isolates from the nose of training soldiers in kerman in 2012

8 laboratory evaluation of phenotypic detection methods of methicillin-resistant staphylococcus aureus

9 staphylococcus aureus, evolución de un viejo patógeno the evolution of an old pathogen called staphylococcus aureus

10 Characterization of Community Acquired Staphylococcus aureus Associated with Skin and Soft Tissue Infection in Beijing: High Prevalence of PVL+ ST398

11 Indole-nitroimidazole conjugates as efficient manipulators to decrease the genes expression of methicillin-resistant Staphylococcus aureus.

12 Range Expansion and the Origin of USA300 North American Epidemic Methicillin-Resistant Staphylococcus aureus

13 The Effect of Vacuum-Assisted Closure Therapy on Methicillin-Resistant Staphylococcus aureus Wound Biofilms.

14 Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

15 Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus

16 Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient

17 Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China

18 Community-acquired methicillin-resistant Staphylococcus aureus from ST1 lineage harboring a new SCCmec IV subtype (SCCmec IVm) containing the tetK gene

19 Methicillin-resistant Staphylococcus aureus: livestock-associated, antimicrobial, and heavy metal resistance

20 Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant

21 Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis

22 Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis

23 Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia

24 Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections

25 Dose-response associations of methicillin-resistant Staphylococcus aureus between school environmental contamination and nasal carriage by elementary students

26 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

27 A prospective cohort study of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus carriage in neonates: the role of maternal carriage and phenotypic and molecular characteristics

28 Distribution of sasX, pvl, and qacA/B genes in epidemic methicillin-resistant Staphylococcus aureus strains isolated from East China

29 Investigating a rare methicillin-resistant Staphylococcus aureus strain: first description of genome sequencing and molecular characterization of CC15-MRSA

30 Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]

31 Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia

32 Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia

33 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

34 Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro

35 Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range

36 Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature

37 Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus

38 Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates

39 Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital

40 An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

41 Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria

42 Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcus aureus surveillance: a 60-month study

43 Methicillin-resistant Staphylococcus aureus in HIV-infected patients

44 Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus

45 Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

46 Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus

47 Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus

48 Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus

49 Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient

50 Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China

51 Community-acquired methicillin-resistant Staphylococcus aureus from ST1 lineage harboring a new SCCmec IV subtype (SCCmec IVm) containing the tetK gene

52 Methicillin-resistant Staphylococcus aureus: livestock-associated, antimicrobial, and heavy metal resistance

53 Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant

54 Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis

55 Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis

56 Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia

57 Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections

58 Dose-response associations of methicillin-resistant Staphylococcus aureus between school environmental contamination and nasal carriage by elementary students

59 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

60 A prospective cohort study of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus carriage in neonates: the role of maternal carriage and phenotypic and molecular characteristics

61 Distribution of sasX, pvl, and qacA/B genes in epidemic methicillin-resistant Staphylococcus aureus strains isolated from East China

62 Investigating a rare methicillin-resistant Staphylococcus aureus strain: first description of genome sequencing and molecular characterization of CC15-MRSA

63 Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]

64 Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia

65 Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia

66 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

67 Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro

68 Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range

69 Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature

70 Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus

71 Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates

72 Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital

73 An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

74 Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria

75 Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcus aureus surveillance: a 60-month study

76 Methicillin-resistant Staphylococcus aureus in HIV-infected patients

77 Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus

78 Resistance of Synthetic and Biologic Surgical Meshes to Methicillin-Resistant Staphylococcus aureus Biofilm: An In Vitro Investigation

79 Antibacterial Activity of Honey against Methicillin-Resistant Staphylococcus aureus: A Laboratory-Based Experimental Study

80 Prevalence of methicillin-resistant Staphylococcus aureus among large commercial pig herds in South Africa

81 Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4′)-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain

82 Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain

83 Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L)

84 Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.

85 Microbiology of Pediatric Orbital Cellulitis and Trends in Methicillin-Resistant Staphylococcus aureus Cases

86 Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus.

87 Nasal carriage of Methicillin-resistant Staphylococcus aureus among healthy population of Kashmir, India

88 Methicillin-Resistant Staphylococcus aureus Endovascular Infection in a Neonate: Prolonged, Safe, and Effective Use of Daptomycin and Enoxaparin.

89 Antibacterial activity and mechanism of Litsea cubeba essential oil against methicillin-resistant Staphylococcus aureus (MRSA)

90 Costs and Benefits of Alternative Strategies to Control the Spread of Livestock-Acquired Methicillin-Resistant Staphylococcus Aureus From Pig Production.

91 Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections.

92 Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection

93 Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus

94 Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

95 Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives

96 Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus Infection

97 Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003

98 Community-associated methicillin-resistant Staphylococcus aureus : Reconsideration of therapeutic options

99 An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients

100 Methicillin-Resistant Staphylococcus aureus: An Evolving Clinical Challenge

101 Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection

Keyword Connections

Journals

Research Groups

Bibliographies